Advertisement

Topics

Global Acute Ischemic Stroke Therapeutics Market 20172021 [Report Updated: 09082017] Prices from USD $3500

18:39 EDT 21 Aug 2017 | BioPortfolio Reports

About Acute Ischemic Stroke Therapeutics

AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics market is expected to register a low single digit market growth during the forecast period. The marginal growth rate is attributed to the lack of approved drugs in this area, the presence of alternative therapies, extensive use of generics, and unmet needs for anticoagulant reversal agents.

Technavio's analysts forecast the global acute ischemic stroke therapeutics market to grow at a CAGR of 2.11% during the period 20172021.

Covered in this report
The report covers the present scenario and the growth prospects of the global acute ischemic stroke therapeutics market for 20172021. To calculate the market size, the report considers the sales of branded, generic, and offlabel drugs from various drug classes.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Acute Ischemic Stroke Therapeutics Market 20172021, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Bayer
Boehringer Ingelheim
F. HoffmannLa Roche
Sanofi
Other prominent vendors
Biogen
Daiichi Sankyo
Pfizer

Market driver
Increasing adoption of NOACs
For a full, detailed list, view our report

Market challenge
Unmet needs for anticoagulant reversal agents
For a full, detailed list, view our report

Market trend
TBI, a valueaddition in AIS research
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Original Article: Global Acute Ischemic Stroke Therapeutics Market 20172021 [Report Updated: 09082017] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Global Acute Ischemic Stroke Therapeutics Market 20172021 [Report Updated: 09082017] Prices from USD $3500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Stroke - Cerebrovascular Disease (CVA)
A stroke is a serious medical condition that occurs when the blood supply to part of the brain is cut off. Strokes are a medical emergency and prompt treatment is essential because the sooner a person receives treatment for a stroke, the less damage is ...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...